Back
Air Liquide SA Vs. Summit Therapeutics Industry Stock Comparison
Sell
30
AIQUY
Air Liquide SA
Last Price:
$33.74
Seasonality Move:
4.07%
Buy
61
SMMT
Summit Therapeutics
Last Price:
$23.49
Seasonality Move:
17.04%
Sell
30
Air Liquide SA (AIQUY)
is a Sell
Is Air Liquide SA a Buy, Sell or Hold?
-
The current Air Liquide SA [AIQUY] share price is $33.54. The Score for AIQUY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
AIQUY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $22.10. The Score for SMMT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AIQUY Stock Price Chart
What is Air Liquide SA's stock price today?
-
The Air Liquide SA share price today is $33.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AIQUY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $22.10Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
AIQUY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 61.08 | Buy |
Chaikin Money Flow: | 283397 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.97 - 33.03) | Buy |
Bollinger Bands (100): | (32.99 - 37.35) | Sell |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.21 | Buy |
Relative Strength Index (14 RSI): | 65.9 | Buy |
Chaikin Money Flow: | 4361755 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.36 - 19.3) | Buy |
Bollinger Bands (100): | (16.17 - 22.65) | Buy |
AIQUY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.49 | Buy |
20-day SMA: | 32.33 | Buy |
50-day SMA: | 33.15 | Buy |
200-day SMA: | 35.56 | Sell |
8-day EMA: | 32.7 | Buy |
20-day EMA: | 32.62 | Buy |
50-day EMA: | 33.36 | Buy |
200-day EMA: | 34.78 | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.63 | Buy |
20-day SMA: | 18.42 | Buy |
50-day SMA: | 18.75 | Buy |
200-day SMA: | 13.34 | Buy |
8-day EMA: | 19.07 | Buy |
20-day EMA: | 18.59 | Buy |
50-day EMA: | 18.61 | Buy |
200-day EMA: | 14.45 | Buy |
Air Liquide SA Earnings Growth & AIQUY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.44 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.17 per share.
Air Liquide SA Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |